(Q36081916)

12 August 2017

Prevention of spontaneous tumours in female rats by fadrozole hydrochloride, an aromatase inhibitor (English)

1 reference

12 August 2017

Gunson DE

1

1 reference

12 August 2017

Steele RE

series ordinal

2

1 reference

12 August 2017

Chau RY

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

72

1 reference

12 August 2017

72-75

1 reference

12 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.279

12 August 2017

0 references

cites work

Recent developments in aromatase inhibition as a potential treatment for oestrogen-dependent breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Novel aromatase inhibitors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Scientific concepts, value, and significance of chemical carcinogenesis studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Neoplasms and related proliferative lesions in control Sprague-Dawley rats from carcinogenicity studies. Historical data and diagnostic considerations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumor.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Testing for a trend in tumor prevalence rates: I. Nonlethal tumors.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Inhibition of aromatase with CGS 16949A in postmenopausal women

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Changes in multiple or sequential estrogen receptor determinations in breast cancer

11 July 2018

1 reference

12 December 2020

Breast cancer in men. Clinical features, hormone receptor status, and response to therapy

1 reference

12 December 2020

CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo

1 reference

12 December 2020

Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy

1 reference

12 December 2020

Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.279

1 reference

12 August 2017

1 reference

12 August 2017

1 reference